(Press-News.org) 22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR 2013, which showed good device performance and low mortality at 30 days.
"First generation TAVI devices provide significant clinical benefit, but there are opportunities for improvement," explained lead author Ian Meredith, Director of MonashHeart, Southern Health and Professor of Medicine, Monash University, Melbourne, Australia. He suggested that these include controlled deployment, simple, precise and atraumatic aortic/ventricular repositioning, no or trivial paravalvular leakage and lower complication rate.
The Lotus Valve System has been designed to address these issues. The valve is pre-attached to the delivery system, which has a simple handle design, and functions early in deployment for controlled, precise positioning. It is fully retrievable and can be repositioned and has an adaptive seal designed to minimise paravalvular leak.
REPRISE II prospectively evaluated the safety and performance of the Lotus Valve System for TAVI in symptomatic patients with severe calcific aortic stenosis considered high risk for surgical valve replacement. Reporting results for the first 60 patients, Meredith told the conference, "Successful valve implantation was achieved in all patients." The primary endpoint for device performance – mean aortic valve pressure gradient at 30 days compared to a performance goal of 18mmHg – was met. Mean aortic gradient decreased from 47.5+17.2mmHg before the procedure to 11.3+5.2mmHg at 30 days. At the same time effective orifice area increased from 0.6+0.2mmHg to 1.7+0.4mmHg.
"Results showed successful valve implantation in all 60 patients, meeting the primary device performance endpoint," Meredith said. "Importantly, the rate of moderate or greater aortic regurgitation decreased from 18% at the baseline study to 1.9% (one patient) at thirty-day follow up. More than 80% had either no or trivial aortic regurgitation at 30 days," he reported. He pointed out that the very low rate of moderate or greater aortic regurgitation was ten-folder lower than seen in previous trials with other systems, describing this as 'a monumental improvement.' The mortality rate was low – 1.7% at 30 days.
"Valve repositioning and retrieval was performed successfully in all cases when required. And there was no embolisation, ectopic valve deployment or TAV-in-TAV," he added. Patients suffered negligible aortic regurgitation, while other clinical event rates were consistent with those reported for other valves. "These findings suggest the Lotus Valve may be a valuable addition to the armamentarium for the treatment of severe aortic stenosis," he concluded.
Commenting on the implications of the study findings, Stephan Windecker, Professor and Chief of Cardiology, Swiss Cardiovascular Center and Clinical Trials Unit Bern, Bern University Hospital, Switzerland, said, "An important factor is that this is a truly repositional device. And it is exciting that the rate of moderate to severe aortic regurgitation is so low."
### END
Second-generation TAVI device -- Lotus Valve -- shows good performance in REPRISE II
2013-05-23
ELSE PRESS RELEASES FROM THIS DATE:
Milwaukee-York researchers forward quest for quantum computing
2013-05-23
Research teams from UW-Milwaukee and the University of York investigating the properties of ultra-thin films of new materials are helping bring quantum computing one step closer to reality.
An on-going collaboration between physicists from York and the University of Wisconsin, Milwaukee, USA, is focusing on understanding, tailoring and tuning the electronic properties of topological insulators (TI) - new materials with surfaces that host a quantum state of matter – at the nanoscale.
Understanding the properties of thin films of the new materials and integrating them with ...
Breakthrough on Huntington's disease
2013-05-23
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
"We are the first to show that it is possible to prevent the depression symptoms of Huntington's disease by deactivating the diseased protein in nerve cell populations in the hypothalamus in the brain. This is hugely exciting and bears out our previous hypotheses", explains Åsa Petersén, Associate Professor of Neuroscience at Lund University.
Huntington's is a debilitating ...
Researchers suggest boosting body's natural flu killers
2013-05-23
Jerusalem, May 13, 2013 – A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have shown recently that another, more promising, approach is to focus on improving drugs that boost the body's natural flu killer system.
Emergence of new influenza strains, such as the recent avian influenza (H5N1) and swine influenza (H1N1 2009), can lead to the emergence of severe pandemics that pose a major threat to the ...
Biochemistry: Unspooling DNA from nucleosomal disks
2013-05-23
The tight wrapping of genomic DNA around nucleosomes in the cell nucleus makes it unavailable for gene expression. A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now describes a mechanism that allows chromosomal DNA to be locally displaced from nucleosomes for transcription.
In higher organisms the genomic DNA is stored in the cell nucleus, wrapped around disk-shaped particles called nucleosomes, each consisting of two pairs of four different histone proteins and accommodating two loops of DNA. Packed in this way to form chromatin, the DNA is protected, but ...
Anxious men fare worse during job interviews, study finds
2013-05-23
Nervous about that upcoming job interview? You might want to take steps to reduce your jitters, especially if you are a man.
People who are anxious perform more poorly in job interviews, and the effect is worse for men than women, according to new research from the University of Guelph.
"Most job applicants experience interview anxiety prior to and during interviews," said psychology professor Deborah Powell, who conducted the study with PhD student Amanda Feiler.
Anxiety often shows up as nervous tics, difficulty speaking and trouble coming up with answers, all of ...
Regenerating spinal cord fibers may be treatment for stroke-related disabilities
2013-05-23
DETROIT – A study by researchers at Henry Ford Hospital found "substantial evidence" that a regenerative process involving damaged nerve fibers in the spinal cord could hold the key to better functional recovery by most stroke victims.
The findings may offer new hope to those who suffer stroke, the leading cause of long-term disability in adults. Although most stroke victims recover some ability to voluntarily use their hands and other body parts, about half are left with weakness on one side of their bodies, while a substantial number are permanently disabled.
The study ...
The secret lives, and deaths, of neurons
2013-05-23
CHAPEL HILL, N.C. – As the human body fine-tunes its neurological wiring, nerve cells often must fix a faulty connection by amputating an axon — the "business end" of the neuron that sends electrical impulses to tissues or other neurons. It is a dance with death, however, because the molecular poison the neuron deploys to sever an axon could, if uncontained, kill the entire cell.
Researchers from the University of North Carolina School of Medicine have uncovered some surprising insights about the process of axon amputation, or "pruning," in a study published May 21 in ...
First successful treatment of pediatric cerebral palsy with autologous cord blood
2013-05-23
Bochum's medics have succeeded in treating cerebral palsy with autologous cord blood. Following a cardiac arrest with severe brain damage, a 2.5 year old boy had been in a persistent vegetative state – with minimal chances of survival. Just two months after treatment with the cord blood containing stem cells, the symptoms improved significantly; over the following months, the child learned to speak simple sentences and to move. "Our findings, along with those from a Korean study, dispel the long-held doubts about the effectiveness of the new therapy", says Dr. Arne Jensen ...
Bacterium from Canadian High Arctic offers clues to possible life on Mars
2013-05-23
The temperature in the permafrost on Ellesmere Island in the Canadian high Arctic is nearly as cold as that of the surface of Mars. So the recent discovery by a McGill University led team of scientists of a bacterium that is able to thrive at –15ºC, the coldest temperature ever reported for bacterial growth, is exciting. The bacterium offers clues about some of the necessary preconditions for microbial life on both the Saturn moon Enceladus and Mars, where similar briny subzero conditions are thought to exist.
The team of researchers, led by Prof. Lyle Whyte and postdoctoral ...
A hidden population of exotic neutron stars
2013-05-23
Magnetars – the dense remains of dead stars that erupt sporadically with bursts of high-energy radiation – are some of the most extreme objects known in the Universe. A major campaign using NASA's Chandra X-ray Observatory and several other satellites shows magnetars may be more diverse – and common – than previously thought.
When a massive star runs out of fuel, its core collapses to form a neutron star, an ultradense object about 10 to 15 miles wide. The gravitational energy released in this process blows the outer layers away in a supernova explosion and leaves the ...